RCHR — ArcherDX, Income Statement
0.000.00%
Last trade - 00:00
HealthcareMicro Cap
2018 December 31st | 2019 December 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG |
Status: | Final | Final |
Revenue | ||
Total Revenue | 28.5 | 50.6 |
Cost of Revenue | ||
Gross Profit | 18.2 | 34 |
Selling / General / Administrative Expenses | ||
Research And Development | ||
Other Operating Expenses | ||
Total Operating Expenses | 33.4 | 87.8 |
Operating Profit | -4.91 | -37.2 |
Total Net Non Operating Interest Income / Expense | ||
Other Net Non Operating Costs | ||
Net Income Before Taxes | -6.03 | -40.5 |
Provision for Income Taxes | ||
Net Income After Taxes | -5.55 | -41 |
Net Income Before Extraordinary Items | ||
Net Income | -5.55 | -41 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||
Income Available to Common Shareholders Including Extraordinary Items | ||
Diluted Net Income | -5.55 | -41 |
Diluted Weighted Average Shares | ||
Basic EPS Including Extraordinary Items | ||
Diluted EPS Including Extraordinary Items | ||
Diluted EPS Excluding Extraordinary Items | ||
Normalised Income Before Taxes | ||
Normalised Income After Taxes | ||
Normalised Income Available to Common Shareholders | ||
Diluted Normalised EPS | -0.601 | -4.43 |
Dividends per Share |